VANGUARD GROUP INC - SPARK THERAPEUTICS INC ownership

SPARK THERAPEUTICS INC's ticker is ONCE and the CUSIP is 84652J103. A total of 123 filers reported holding SPARK THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SPARK THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$313,984,000
-3.5%
3,237,616
+1.9%
0.01%0.0%
Q2 2019$325,338,000
-5.1%
3,177,757
+5.5%
0.01%
-7.7%
Q1 2019$342,933,000
+200.3%
3,011,358
+3.2%
0.01%
+160.0%
Q4 2018$114,185,000
-25.9%
2,917,324
+3.3%
0.01%
-16.7%
Q3 2018$154,005,000
-32.5%
2,823,168
+2.5%
0.01%
-40.0%
Q2 2018$228,031,000
+29.6%
2,755,322
+4.3%
0.01%
+25.0%
Q1 2018$175,942,000
+32.8%
2,642,188
+2.5%
0.01%
+33.3%
Q4 2017$132,524,000
-39.7%
2,577,279
+4.5%
0.01%
-40.0%
Q3 2017$219,890,000
+91.3%
2,466,238
+28.2%
0.01%
+66.7%
Q2 2017$114,968,000
+17.9%
1,924,463
+5.3%
0.01%
+20.0%
Q1 2017$97,487,000
+12.5%
1,827,660
+5.2%
0.01%0.0%
Q4 2016$86,674,000
-14.3%
1,736,974
+3.1%
0.01%
-16.7%
Q3 2016$101,164,000
+30.8%
1,684,375
+11.4%
0.01%
+20.0%
Q2 2016$77,340,000
+123.3%
1,512,600
+28.9%
0.01%
+150.0%
Q1 2016$34,641,000
-30.2%
1,173,880
+7.2%
0.00%
-33.3%
Q4 2015$49,603,000
+53.3%
1,094,738
+41.2%
0.00%
+200.0%
Q3 2015$32,365,000
+16.7%
775,571
+68.5%
0.00%
-50.0%
Q2 2015$27,743,000
-15.6%
460,315
+8.5%
0.00%0.0%
Q1 2015$32,890,000424,3870.00%
Other shareholders
SPARK THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Casdin Capital, LLC 170,000$5,017,0005.76%
Rock Springs Capital Management LP 580,500$17,131,0001.44%
Opus Point Partners Management, LLC 31,500$930,0000.72%
Bain Capital Public Equity Management, LLC 424,114$12,516,0000.46%
Baker Brothers Advisors 1,262,382$37,253,0000.39%
MARINER INVESTMENT GROUP LLC 34,350$1,014,0000.28%
Eventide Asset Management 150,000$4,427,0000.25%
Virtus ETF Advisers LLC 5,251$155,0000.21%
EMERALD ADVISERS, LLC 123,970$3,658,0000.18%
Endurant Capital Management LP 17,500$516,0000.17%
View complete list of SPARK THERAPEUTICS INC shareholders